Prometheus
ArchivedDARPA - Biological Technologies Office
Description
The Prometheus program aims to develop a molecular host prognostic assay to measure infectious disease contagiousness. Prometheus will focus specifically on the early prognosis of pathogen transmission potential prior to the onset of symptoms. By the end of the program, a minimal set of early host biomarkers will be identified in humans that correlate with and predict contagiousness <24 hours after infection.
Who can apply
- Unrestricted
Contact
BAA Coordinator <br/>
DARPA-BAA-16-42@darpa.mil.
- PostedJun 15, 2016
- ClosesAug 2, 2016
- CFDA12.910
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro